Navigation Links
Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar
Date:1/7/2009

RICHMOND, Va., Jan. 7 /PRNewswire/ -- Dr. Ryan Burnette, Director of Alliance Biosciences will lead a trade mission to Singapore January 19, 2009 through January 23, 2009. Dr. Burnette will be promoting the need for international accreditation processes for high-containment biomedical labs as a lynchpin to an effective biosecurity and biosafety preparedness program.

"I am very excited to visit Singapore, a progressive country that has embraced the need for well-designed and operated containment labs and operations," said Dr. Burnette. "I look forward to meeting with academic, governmental and private sector leaders to discuss ways to utilize solid accreditation standards as a foundation for best practices in research and manufacturing, and to partially mitigate the risks of bio-terrorism."

During his visit, Dr. Burnette will speak at the Lab Design Seminar taking place January 19th - 20th at Biopolis, the biomedical R&D hub at one-north, a 200 hectare vibrant hotspot for R&D innovation and test-bedding. Organized by JTC Corporation, the master developer for one-north, the inaugural seminar, a first for Singapore, will be the ideal networking forum for international thought leaders, scientists, developers and other professionals to come together to exchange invaluable insights and experiences on specialty lab design.

"Biopolis has seeded the Biomedical research industry in Singapore and garnered international attention," said Philip Su, Assistant Chief Executive Officer, JTC Corporation. "We are privileged to have Dr. Burnette speak at this event, which will encourage greater sharing between design professionals from all over the world, and break boundaries between different international practices."

On January 20th at 4:15pm, Dr. Burnette will deliver a presentation titled "Working Toward Accreditation Standards". The speech will highlight the significant need for international accreditation standards for high-containment biomedical labs, and will discuss the major similarities and differences of efforts underway in Europe, Canada, the U.S. and other countries to develop benchmarks for design and operational standards of excellence.

"JTC Corporation has created a tremendous forum for international leaders to convene, share ideas and best practices," stated Burnette. "With increased awareness of the need for accreditation standards we will continue to progress toward developing such a platform."

For further information on the trade mission please visit www.alliancebiosciences.com or email info@alliancebiosciences.com. For conference registration information please visit http://www.one-north.com or email one-north@jtc.gov.sg.

About Alliance Biosciences

Alliance Biosciences is the leading biosafety consulting firm in the U.S., addressing the various needs of the biotechnology, pharmaceutical and R&D industries. Serving a diverse clientele in academia, the private and public sectors, Alliance Biosciences provides high-containment laboratory design (BSL -1/2/3/4) guidance, facility inspections and recommendations, operational audits of documentation and SOPs, risk assessments and custom biosafety training curricula. The firm is a division of Alliance Engineering, Inc., enabling the efficient translation of client needs from concept through construction. Led by internationally recognized industry experts, Alliance Biosciences delivers a truly full-service, turnkey approach to biosafety program management. www.alliancebiosciences.com

About one-north

one-north is Singapore's icon of the knowledge economy. It serves to provide an intellectually stimulating and creative environment for entrepreneurs, scientists and researchers to congregate, interact and exchange ideas; an exceptional place where this thriving community will work, live, play and learn. With a focus on knowledge-intensive activities in the biomedical, infocomms and media industries, it is slated to be a vibrant hotspot for innovation and test bedding.

Covering almost 200 hectares, one-north will be developed in phases over a period of 15 to 20 years, integrating residential units, commercial hubs, tertiary and research institutes, sports facilities as well as green lungs. It is strategically located in the Buona Vista area (southern part of Singapore) near the National University of Singapore and Singapore Science Park and aims to be a focal point for research and development and technopreneurial activities.

JTC Corporation was appointed master developer for this project in September 2000.

one-north's home page address on the World Wide Web is http://www.one-north.com


'/>"/>
SOURCE Alliance Biosciences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Imugene and Merial Establish Strategic Alliance
2. PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies
3. SciQuest Announces Strategic Alliance with QIAGEN
4. Universal Bioenergy, Inc. Seeks Algae Feedstock Companies for Acquisition, Alliance, and Joint Venture Opportunities for Biodiesel Production
5. Environmental Power Corporation and Organix, Inc. Establish Alliance to Produce High Value Soil Amendment Products
6. Commonwealth Care Alliance Selects Casenet To Unify Patient Information and Improve Care for Massachusetts Members
7. PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases
8. Swedish Neuroscience Institute and Institute for Systems Biology in Seattle Form Alliance to Learn More about Brain Diseases
9. Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition
10. GlaxoSmithKline and Cellzome Announce Major Strategic Alliance
11. Campbell Alliance Sales Practice to Present at CBIs Leadership Summit on Evolving the Pharma Sales Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:6/20/2016)... June 20, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring ... involved, it has secured the final acceptance by ... for Managed Access Systems (MAS) installed. Furthermore, Securus ... to be installed by October, 2016. MAS distinguishes ...
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
Breaking Biology News(10 mins):